Gates Foundation
  • Grant Opportunities
  • Partnerships
  • Systems

Microbial Biosensor for Diagnosing Leishmaniasis

Darren Zhu of Synbiosys, LLC in the U.S. aims to produce a low-cost diagnostic platform that can rapidly diagnose leishmaniasis in field conditions. He will engineer a bacterium with cell surface receptors that are activated and amplified by the presence of Leishmania proteases to produce a colorimetric readout. This biologic system could be extended to the rapid diagnosis of other infectious diseases.

More information about Apply Synthetic Biology to Global Health Challenges (Round 7)

Share this content